Regeneron has made billions from its Covid-19 drug, and it has new drugs like Dupixent that could make many billions more. More
Articles
UBER Stock Price Predictions: Why One Analyst Thinks Uber Shares Could Double
UBS analyst Lloyd Walmsley recently initiated coverage on UBER stock with a price target of $80. That represents an upside of more than 100%. More
Why You Should Avoid Meten Holdings Stock
If you need it spelled out for you in English, METX stock is an 'avoid' at any price given this year's multiple history lessons in meme stocks More
Rumble SPAC Merger: 9 Things to Know About the YouTube Competitor as CFVI Stock Surges
CFVI stock is shooting up after Rumble announced it will be merging with the shell company. Here's what investors should know. More
EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today
Investors in Express (EXPR) stock are celebrating on Thursday thanks to the release of the company's Q3 2021 earnings report. More
